Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components

Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components

Abstract Background The metabolic syndrome (MetS) comprises several cardiometabolic risk factors associated with increased risk for both type 2 diabetes and cardiovascular disease. Skin autofluorescence (SAF), a non-invasive biomarker of advanced glycation end products accumulation, is associated wi...

Full description

Bibliographic Details
Main Authors: Robert P. van Waateringe, Sandra N. Slagter, Andre P. van Beek, Melanie M. van der Klauw, Jana V. van Vliet-Ostaptchouk, Reindert Graaff, Andrew D. Paterson, Helen L. Lutgers, Bruce H. R. Wolffenbuttel
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Diabetology & Metabolic Syndrome
Online Access:http://link.springer.com/article/10.1186/s13098-017-0241-1

Internet

http://link.springer.com/article/10.1186/s13098-017-0241-1

Similar Items